Home/Oncovita/Patrick Spies

PS

Patrick Spies

Chief Financial Officer

Therapeutic Areas

Oncovita Pipeline

Drug	Indication	Phase
MVdeltaC	Pleural Mesothelioma	Pre-clinical
Measovir®-based candidate	Bladder Cancer	Pre-clinical
Measovir®-based Prophylactic Vaccine (with Unither)	Undisclosed	Research/Pre-clinical

Leadership Team at Oncovita

Jean-François Le Bigot

Executive Chairman

Stéphane Altaba

Chief Executive Officer

Frédéric Tangy

Co-Founder and Chief Scientific Officer

Véronique Riebbels

Clinical Development Coordinator

Collaborator (INSERM Unit 892, Nantes CHU)

View full Oncovita profile